Filing Details
- Accession Number:
- 0001181431-13-014206
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-04 19:41:01
- Reporting Period:
- 2013-02-28
- Filing Date:
- 2013-03-04
- Accepted Time:
- 2013-03-04 19:41:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1401923 | Map Pharmaceuticals Inc. | MAPP | Pharmaceutical Preparations (2834) | 200507047 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1413822 | Anastasios Gianakakos | 2400 Bayshore Parkway, Suite 200 Mountain View CA 94043 | Svp, Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-02-28 | 20,000 | $10.37 | 38,438 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-28 | 20,000 | $25.00 | 18,438 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2013-02-28 | 20,000 | $0.00 | 20,000 | $10.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
50,000 | 2019-02-10 | No | 4 | M | Direct |
Footnotes
- The transaction was made pursuant to a 10b5-1 trading plan in effect at the time of the transaction.
- Fully exercisable.